Mumbai: No Relief For Wholesalers Who Sold Fake Covid-19 Medicine

Mumbai : A sessions court in Dindoshi on Friday rejected anticipatory bail pleas of two drug wholesalers booked by the Vanrai and Samta Nagar police stations for stocking spurious Favimax 400 drug, widely used in the treatment of Covid-19 infection.

On 24 May, upon a tip-off, the Food and Drug Administration (FDA) raided three wholesalers in the suburbs of Kandivali and Goregaon areas. In Kandivali, it found fake drug worth Rs 21 lakh and in Goregaon Rs 1 crore. Accordingly, Samta Nagar police station had booked wholesaler Nilesh Khimani and Vanrai police booked Manjiri Kadam by Vanrai police for the offences of cheating, forgery and under provisions of the Drugs and Cosmetics Act.

Both had approached the court apprehending arrest and claimed in their pleas that they did not have the knowledge that the drugs were not genuine, that they were only sellers and had no role in the offence.

Additional Public Prosecutor Sachin Jadhav had opposed grant of relief to them and told the court that the duo procured the fake drug, having knowledge that they are not genuine, from the main accused Sudeep Mukherjee, the owner of Max Relief Healthcare in Himachal Pradesh. Probe by the FDA had found that the company did not exist, but its ‘owner’ Mukherjee sold the fake drugs manufactured by a pharma lab employee in Uttar Pradesh, whom another person helped package it. Prosecutor Jadhav further pointed out that it was only a profiteering motive during a pandemic, with which the duo purchased a huge stock of the fake drug. Their custodial interrogation was required, he told the court, to find where they had sold the spurious drug. Additional Sessions Judge SU Baghele rejected relief to the duo.

  • Related Posts

    National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

    New Delhi:  The National Pharmaceutical Pricing Authority (NPPA) has notified retail price of 42 new drugs under the provisions of the Drugs Prices Control Order (DPCO), 2013, including anti hypertensive,…

    World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

    New Delhi– In a landmark development for global child health, the World Health Organization (WHO) has granted prequalification to Coartem® Baby (artemether-lumefantrine), the first and only antimalarial medicine specifically developed…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    A SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular Intercontinental

    National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

    National Pharmaceutical Pricing Authority notifies retail price of 42 new drugs

    World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

    World’s First Malaria Treatment for Newborns and Young Infants Receives WHO Prequalification

    FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

    FIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged Documents

    Laughing all the Way to Health with Sir Ganga Ram Hospital

    Laughing all the Way to Health with Sir Ganga Ram Hospital

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson

    Semaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik Jonsson